Lung Neoplasms: all 7,334 studies
Page 9 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLCNot yet recruitingNCT06475755Phase 2
- Understanding Lung Cancer Related Risk Factors and Their ImpactNot yet recruitingNCT06473870
- Insomnia in Patients With Metastatic Lung CancerRecruitingNCT06472804
- Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine TumorsRecruitingNCT06472388Phase 2
- The Lymphocytic Infiltrate of Lung Tumors.RecruitingNCT06470607
- A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer PatientsNot yet recruitingNCT06469879Phase 3
- Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung CancerRecruitingNCT06467786Phase 4
- A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed ImmunotherapyRecruitingNCT06467500Phase 2
- Phase II Trial of Almonertinib Plus Lastet for EGFR+ Non-small Cell Lung CancerNot yet recruitingNCT06463171Phase 2
- Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung CancerNot yet recruitingNCT06462105Not applicable
- Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLCNot yet recruitingNCT06456138Phase 1/2
- TIL Therapy in Non-small-cell Lung Cancer (NSCLC) PatientsRecruitingNCT06455917Phase 2
- Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06454890Phase 1/2
- Efficacy and Safety of Multimode Thermal Therapy in the Treatment of Early Peripheral Lung CancerNot yet recruitingNCT06453889Not applicable
- Gumarontinib Combined With 3rd EGFR-TKI in Patients With Non-small Cell Lung Cancer.Not yet recruitingNCT06452433Phase 2
- Prevention of Smoking Related DiseasesRecruitingNCT06451029
- Observation on the Frailty Status of Lung Cancer PatientsRecruitingNCT06448455
- Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC TreatmentRecruitingNCT06445881Phase 2
- Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal MetastasesRecruitingNCT06440954Phase 2
- Benefit of Spectral Information in Patients Suspected for Lung CancerRecruitingNCT06440616Not applicable
- An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung CancerRecruitingNCT06436885Early Phase 1
- Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLCNot yet recruitingNCT06436144Phase 2
- A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLCNot yet recruitingNCT06434740Phase 2
- Care Needs in Lung Cancer Patients Receiving ImmunotherapyRecruitingNCT06433206
- Smoking Cessation CM for Veterans With or at Risk for CancerRecruitingNCT06432985Not applicable
- Accelerated Pulmonary Rehabilitation in the Preoperative PeriodRecruitingNCT06432972Not applicable
- PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung CancerRecruitingNCT06429696Phase 2
- The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer PatientsRecruitingNCT06428422Not applicable
- Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung CancerRecruitingNCT06427954Not applicable
- A Registry for People With Lung CancerRecruitingNCT06424327
- A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid BiopsyNot yet recruitingNCT06422637Not applicable
- A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.RecruitingNCT06421298Phase 2
- Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer CenterRecruitingNCT06420206Not applicable
- Exploration of Optical Coherence Tomography-Guided Transbronchial Biopsy in Peripheral Pulmonary LesionsRecruitingNCT06419114
- A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLCRecruitingNCT06418412
- Clinical Study of 18F-Alfatide Injection PET/CTNot yet recruitingNCT06416852Phase 3
- The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)RecruitingNCT06412172
- Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube DrainageRecruitingNCT06410716Not applicable
- Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and ImmunotherapyRecruitingNCT06410300
- Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung CancerNot yet recruitingNCT06409416
- A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung CancerRecruitingNCT06406673Phase 2
- Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung CancerRecruitingNCT06406660Not applicable
- Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung CancerRecruitingNCT06406608Not applicable
- FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLCRecruitingNCT06403111Phase 2
- A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer PatientsRecruitingNCT06402981
- A Study of Sofe-M in Participants With Selected Advanced Solid TumorsRecruitingNCT06400472Phase 1
- Postoperative Pain Management on Patients Undergoing Lung Tumor ResectionNot yet recruitingNCT06397807
- Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung CancerNot yet recruitingNCT06394427
- FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumRecruitingNCT06393816Phase 2
- Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)Enrolling by invitationNCT06391749
- Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung CancerNot yet recruitingNCT06391008Phase 2
- ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICIRecruitingNCT06388031Phase 2
- Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening PathwayRecruitingNCT06387017Not applicable
- SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine CarcinomaRecruitingNCT06384482Phase 1
- Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie RecipeRecruitingNCT06381960Phase 2
- A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on LorlatinibRecruitingNCT06378892Phase 2
- A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer PatientsRecruitingNCT06377124Not applicable
- Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.RecruitingNCT06376097
- A Study of GC203 TIL in Advanced Malignant Solid TumorsRecruitingNCT06375187Phase 1
- PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLCNot yet recruitingNCT06375109Phase 2
- Exercise in Patients With Advanced Non-small Cell Lung CancerNot yet recruitingNCT06374160Not applicable
- Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLCRecruitingNCT06369181
- Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II TrialRecruitingNCT06363734Phase 2
- Real World Study of Lolatinib for Advanced ALK+ NSCLC PatientsRecruitingNCT06361589
- Increasing Equity in Lung Cancer ScreeningRecruitingNCT06360822Not applicable
- Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) ScanRecruitingNCT06358222
- Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung CancerRecruitingNCT06357598Phase 4
- Prehab for Lung and Esophageal CancerRecruitingNCT06354959Not applicable
- An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain MetastasisRecruitingNCT06352502
- Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung CancerRecruitingNCT06349252
- Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLCRecruitingNCT06348927Phase 2
- Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLCNot yet recruitingNCT06348030Not applicable
- Mediastinal EBUS Cryobiopsy Study In SwedenRecruitingNCT06347939
- Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerRecruitingNCT06343402Phase 1
- Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKIRecruitingNCT06343064Phase 1/2
- To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)RecruitingNCT06341660Phase 2
- Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung CancerRecruitingNCT06341530Phase 2
- Volatolomic and Proteomic Profile for Early Diagnosis of Lung CancerRecruitingNCT06341387
- A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung CancerRecruitingNCT06331650Phase 2
- Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and ResectionRecruitingNCT06331455Phase 2
- Anesthesia and Non-small Cell Lung Cancer RecurrenceRecruitingNCT06330038Phase 4
- DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIsRecruitingNCT06329908Early Phase 1
- Assessment System of Sarcopenia in Lung Cancer PatientsRecruitingNCT06327594
- Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.RecruitingNCT06326086
- Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL TrialEnrolling by invitationNCT06324110Not applicable
- A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung CancerRecruitingNCT06323265
- Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)Not yet recruitingNCT06323148Phase 3
- RealMove (Lung): Assessing Tumour Motion With Dynamic MRIRecruitingNCT06322329Not applicable
- Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung CancerNot yet recruitingNCT06319313Phase 2/3
- Quantitative Evaluation of the Impact of Relaxing Eligibility Criteria for Lung Cancer Based on Real-world DataRecruitingNCT06314542
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly PatientsRecruitingNCT06311981Phase 2
- Oral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 InhibitorRecruitingNCT06310915
- A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.Not yet recruitingNCT06306560Phase 2
- Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene MutationsNot yet recruitingNCT06299371Phase 2
- Serplulimab Combined With CCRT for LS-SCLC.RecruitingNCT06295926Phase 2
- Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence DeviceRecruitingNCT06295497Not applicable
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsRecruitingNCT06293898Phase 1
- Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scanEnrolling by invitationNCT06293833Not applicable
- Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerRecruitingNCT06287775Phase 1/2